Philips to repurchase up to 6 million shares to cover long-term incentive and employee stock purchase plans

January 29, 2020 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA) today announced that it will repurchase up to 6 million shares to cover certain of its obligations arising from its long-term incentive and employee stock purchase plans. At the current share price, the shares represent an amount of up to approximately EUR […]

Seatrade Cruise Global Announces Panelists, Themes for Anticipated 2020 State of the Global Cruise Industry Keynote

World’s Largest Cruise Industry Event Returns to Miami Beach Convention Center 20-23 April 2020 Lucy Hockings NEW YORK, Jan. 28, 2020 (GLOBE NEWSWIRE) — Seatrade Cruise Global, the cruise industry’s leading annual business-to-business event, announces its 2020 State of the Global Cruise Industry Keynote lineup – launching its 35th anniversary edition opening session on 21 […]

Four-year data from ILLUMENATE Pivotal trial reaffirms safety profile of Philips Stellarex low-dose Drug-Coated Balloon

January 28, 2020 Mortality rates similar to standard of care through four years with excellent rate of follow-up compliance Philips Stellarex is the only low-dose Drug-Coated Balloon (DCB) to demonstrate sustained treatment effect and high safety profile through four years  Amsterdam, the Netherlands and Leipzig, Germany – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health […]

Top Trends Driving Technology Innovation Investments in 2020 Revealed by Virtusa

Financial Services, Insurance, and Life Sciences Leading in Innovation to Start the New Decade SOUTHBOROUGH, Mass., Jan. 28, 2020 (GLOBE NEWSWIRE) — Virtusa Corporation (NASDAQ GS:VRTU), a global provider of digital strategy, digital engineering, and IT services and solutions that help clients change and disrupt markets through innovation engineering, today announced the findings of detailed research identifying trends that will […]

Philips delivers Q4 sales of EUR 6 billion, with 3% comparable sales growth; income from continuing operations amounted to EUR 550 million and Adjusted EBITA margin increased to 17.9%

January 28, 2020 Fourth-quarter highlights Sales amounted to EUR 6 billion, with 3% comparable sales growth Comparable order intake increased 3% Income from continuing operations was EUR 550 million, compared to EUR 723 million in Q4 2018 Adjusted EBITA margin improved by 50 basis points to 17.9% of sales, compared to 17.4% of sales in […]

GLOBAL INFRASTRUCTURE PARTNERS ANNOUNCES THE ELECTION OF TWO NEW PARTNERS

New York, NY, Jan. 27, 2020 (GLOBE NEWSWIRE) — GIobal Infrastructure Partners (“GIP”), a leading independent global infrastructure investor, today announced that Julie Ashworth and Philip Iley have been elected Partners of the Firm, effective January 1, 2020. Julie Ashworth joined GIP in 2012 and has been a crucial contributor to the success of the […]

Altus Group Report Reveals CRE Industry on Verge of Significant PropTech Consolidation as Technology Adoption Reaches Tipping Point

Data usability challenges continue to hinder productivity while a majority of CRE leaders believe automation will impact jobs and transform the workforce TORONTO, Jan. 27, 2020 (GLOBE NEWSWIRE) — Altus Group Limited (“Altus Group”) (TSX: AIF), a leading provider of software, data solutions and independent advisory services to the global commercial real estate (“CRE”) industry, […]

Helsinn Group Grants Exclusive Licensing Rights to Berlin-Chemie AG, a company of the Menarini Group, for ONICIT®/ALOXI® and AKYNZEO® in Russia and CIS region

Helsinn Group Grants Exclusive Licensing Rights to Berlin-Chemie AG, a company of the Menarini Group, for ONICIT®/ALOXI® and AKYNZEO® in Russia and CIS region Berlin-Chemie AG has been granted exclusive rights to import, distribute, promote, market and sell AKYNZEO® and ONICIT® (ALOXI®) in Russia and CIS region from January 2020 The two products will provide […]

Khondrion announces first patients dosed in Phase IIb study of Sonlicromanol for mitochondrial diseases

Khondrion announces first patients dosed in Phase IIb study of Sonlicromanol for mitochondrial diseases Study will examine impact on cognitive function from one of the most advanced disease-modifying drug treatments for mitochondrial disease in development NIJMEGEN, the Netherlands – Monday January 27, 2020: Khondrion, a clinical-stage pharmaceutical company discovering and developing therapies targeting mitochondrial disease, […]